Anheuser-Busch InBev SA/NV (FRA:1NBA)
Germany · Delayed Price · Currency is EUR | Market Cap | 148.66B +42.1% |
| Revenue (ttm) | 54.81B +7.0% |
| Net Income | 8.16B +31.1% |
| EPS | 4.06 +32.6% |
| Shares Out | n/a |
| PE Ratio | 18.72 |
| Forward PE | 18.16 |
| Dividend | 0.81 (1.06%) |
| Ex-Dividend Date | May 7, 2026 |
| Volume | 300 |
| Open | 75.46 |
| Previous Close | 75.04 |
| Day's Range | 75.46 - 76.00 |
| 52-Week Range | 51.46 - 76.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About Anheuser-Busch InBev
Anheuser-Busch InBev SA/NV produces and sells beer in North America, Middle Americas, South America, Europe, the Middle East, Africa, and the Asia Pacific. It operates through North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies segments. The company also offers flavored malt beverages, soft drinks, spirit-based ready-to-drink cocktails and beverages, and energy drinks. In addition, it operates BEES, a business-to-business digital commerce platform; on-demand delivery platforms under the Zé ... [Read more]
Financial Performance
In 2025, Anheuser-Busch InBev's revenue was $59.32 billion, a decrease of -0.75% compared to the previous year's $59.77 billion. Earnings were $6.84 billion, an increase of 16.77%.
Financial numbers in USD Financial StatementsNews
Is Anheuser-Busch InBev SA/NV (BUD) Overvalued After 3.9% Rally? GF Value Says Overvalued
Is Anheuser-Busch InBev SA/NV (BUD) Overvalued After 3.9% Rally? GF Value Says Overvalued
This Stock's for You: Buy Bud's ‘Diet Coke' Moment
Americans and Europeans are drinking less alcohol, but that's no problem for AB InBev. The Bud and Michelob brewer's shares are trading at a discount as new zero-alcohol concoctions hit store shelves.
This Stock's for You: Bud's ‘Diet Coke' Moment Is the Time to Buy
Americans and Europeans are drinking less alcohol, but that's no problem for AB InBev. The Bud and Michelob brewer's shares are trading at a discount as new zero-alcohol concoctions hit store shelves.
Dream cafe goes up in tobacco smoke; Russell Brand trial begins; and SA’s Michelin stars
Want to get this in your inbox every weekday? Sign up for the Morning Mail here , and finish your day with our Politics, really newsletter . Morning everyone. We look at the collateral damage to busin...
BUD Maintained by TD Cowen -- Price Target Lowered to $85.00
BUD Maintained by TD Cowen -- Price Target Lowered to $85.00
AB InBev price target lowered to $85 from $89 at TD Cowen
TD Cowen lowered the firm’s price target on AB InBev (BUD) to $85 from $89 and keeps a Hold rating on the shares. The firm adjusted targets in the food,…
A Look at Anheuser-Busch InBev SA/NV (BUD) After 3.7% Gain -- GF Value $68.51 vs Price $77.41
A Look at Anheuser-Busch InBev SA/NV (BUD) After 3.7% Gain -- GF Value $68.51 vs Price $77.41
AB InBev price target raised to EUR 95 from EUR 93 at RBC Capital
RBC Capital analyst James Edwardes Jones raised the firm’s price target on AB InBev (BUD) to EUR 95 from EUR 93 and keeps an Outperform rating on the shares. The…
Zacks Industry Outlook Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors
Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors have been highlighted in this Industry Outlook article.
SA's first musical theatre company brings talent home in debut stage
SA's first musical theatre company brings talent home in debut stage
BUD Looks 13.0% Overvalued on GF Value™ as Dividend Sustainability Remains Key
BUD Looks 13.0% Overvalued on GF Value™ as Dividend Sustainability Remains Key
Michelob Ultra Shoots and Scores Multiyear NHL Partnership
The Anheuser-Busch brand becomes an official beer sponsor of the NHL in the US.
Anheuser-Busch InBev Targets 5% to 9% Annual EBIT Growth in Reignite Phase
Anheuser-Busch InBev SA/NV NYSE: BUD outlined a new medium-term target for 5% to 9% average annual EBIT growth as the brewer shifts its primary performance measure from EBITDA to EBIT, citing improved...
BUD Looks 12.5% Overvalued on GF Value™ as Dividend Sustainability Remains Key
BUD Looks 12.5% Overvalued on GF Value™ as Dividend Sustainability Remains Key
AB InBev says new medium-term outlook for EBIT growth of 5%-9%
AB InBev (BUD) CFO Fernando Tennenbaum stated while presenting at the company’s capital markets day, according to a speech transcript published by the company: “When we introduced our medium-term outl...
Anheuser-Busch InBev Transcript: CMD 2026 Day 2 Part 2
The event outlined a shift to EBIT as the key performance metric, targeting 5%-9% medium-term growth, supported by disciplined capital allocation, margin expansion, and strong free cash flow. Continued investment in brands, digital platforms, and Beyond Beer, along with a focus on organic growth and portfolio optimization, positions the business for superior shareholder value creation.
Anheuser-Busch InBev Slides: FY 2026
Anheuser-Busch InBev has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 23, 2026.
Anheuser-Busch InBev Maps Organic Growth Engine at Capital Markets Day
At its Capital Markets Day, Anheuser-Busch InBev SA/NV NYSE: BUD emphasized its corporate culture, long-term growth strategy and U.S. sales capabilities, with CEO Michel Doukeris describing ownership ...
Anheuser-Busch InBev Transcript: CMD 2026 Day 2 Part 1
Ownership and culture are central, with simplified principles and a pivot to organic growth. Innovation in non-alcoholic and Beyond Beer, disciplined CapEx, and mega marketing platforms drive results. U.S. sales leverage tech, wholesaler partnerships, and local activations for market share gains.
Anheuser-Busch InBev Slides: FY 2026
Anheuser-Busch InBev has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 23, 2026.
Anheuser-Busch InBev Unveils ‘Reignite' Growth Plan at Capital Markets Day
Anheuser-Busch InBev SA/NV NYSE: BUD used its 2026 Capital Markets Day in St. Louis to outline the next phase of its 10-year strategy, emphasizing organic growth, portfolio expansion, digital platform...
Smaller packs, more protein: AB InBev to adapt drinks to shifting tastes
Anheuser-Busch InBev will sell smaller pack sizes, beers with added protein or electrolytes and push further into drinks beyond beer, executives said on Tuesday, as the top brewer looks to grow amid...
Anheuser-Busch InBev Transcript: CMD 2026 Day 1
The event detailed a successful transformation to organic, compounding growth, with EBITDA and net revenue rising steadily since 2021. Digital and AI capabilities, mega brand focus, and portfolio simplification have driven global market share gains and innovation. The U.S. business is rebalanced for growth, with leading brands in beer and spirits, and BEES and D2C platforms are scaling rapidly.
Anheuser-Busch InBev Slides: FY 2026
Anheuser-Busch InBev has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 22, 2026.
BUD Looks 14.3% Overvalued on GF Value™ Amid $23M Michelob ULTRA Expansion
BUD Looks 14.3% Overvalued on GF Value™ Amid $23M Michelob ULTRA Expansion